Literature DB >> 8221257

Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy.

B Zimmerman1, A Lanner, I Enander, R S Zimmerman, C G Peterson, S Ahlstedt.   

Abstract

Blood eosinophils, and serum levels of the eosinophil proteins, eosinophil cationic protein (ECP) and eosinophil protein X (EPX) were measured in childhood asthma. Seventeen patients mean age 11.9 years who were symptomatic with asthma, were enrolled in a study examining the eosinophil counts and eosinophil proteins at the onset of study and after treatment in relation to changes in their baseline forced expiratory volume at 1 second (FEV1) and % predicted FEV1. The patients with symptomatic asthma were compared with 17 patients mean age 12.0 years with asymptomatic asthma maintained on daily inhaled steroid and 13 patients, mean age 12.0 years, without asthma but with urticaria who served as non-asthma controls. Patients with symptomatic asthma did not have significantly higher initial eosinophil counts compared with those with asymptomatic asthma (0.43 x 10(9)/l vs 0.26 x 10(9)/l, P = 0.09) but had higher serum ECP levels (28.9 micrograms/l vs 18.5 micrograms/l). Both asthma patient groups had significantly higher serum ECP levels (P < 0.01) than the controls (9.8 micrograms/l). After therapy consisting of increased dose of inhaled steroids and/or oral steroids, patients in the symptomatic asthma group demonstrated a significant rise in FEV1 (1.67 l/sec at Visit 1 vs 2.08 l/sec at Visit 2, P < 0.001). A similar rise was seen for % predicted FEV1.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221257     DOI: 10.1111/j.1365-2222.1993.tb00895.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  10 in total

1.  Biomarkers of eosinophil involvement in allergic and eosinophilic diseases: review of phenotypic and serum markers including a novel assay to quantify levels of soluble Siglec-8.

Authors:  Ho Jeong Na; Robert G Hamilton; Amy D Klion; Bruce S Bochner
Journal:  J Immunol Methods       Date:  2012-06-06       Impact factor: 2.303

2.  A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide.

Authors:  C Heuck; L Heickendorff; O D Wolthers
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

3.  Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma.

Authors:  C K Wong; C Y Ho; F W Ko; C H Chan; A S Ho; D S Hui; C W Lam
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

4.  Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (Fc epsilon RII/sCD23) in childhood bronchial asthma.

Authors:  I Türktaş; S Demirsoy; E Koç; N Gökçora; S Elbeg
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

5.  Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma.

Authors:  Kyung Won Kim; Kyung Eun Lee; Eun Soo Kim; Tae Won Song; Myung Hyun Sohn; Kyu-Earn Kim
Journal:  Lung       Date:  2007-03-28       Impact factor: 2.584

6.  Regulation of the interleukin-5 receptor alpha-subunit on peripheral blood eosinophils from healthy subjects.

Authors:  C Hellman; G Halldén; B Hylander; J Lundahl
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 7.  Cellular and immunological markers of allergic and intrinsic bronchial asthma.

Authors:  J C Virchow; C Kroegel; C Walker; H Matthys
Journal:  Lung       Date:  1994       Impact factor: 2.584

8.  Assessment of airway inflammation with exhaled NO measurement.

Authors:  E Hatziagorou; J Tsanakas
Journal:  Hippokratia       Date:  2007-04       Impact factor: 0.471

9.  The impact of reflexology and homeopathy added to conventional asthma treatment on markers of airway inflammation - a randomised study.

Authors:  Ayfer Topcu; Anders Løkke; Leila Eriksen; Lars Peter Nielsen; Ronald Dahl
Journal:  Eur Clin Respir J       Date:  2020-02-26

Review 10.  Eosinophil protein X and childhood asthma: A systematic review and meta-analysis.

Authors:  Hillary Klonoff-Cohen; Mounika Polavarapu
Journal:  Immun Inflamm Dis       Date:  2016-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.